Regeneron: Seize the Opportunity and Reap the Benefits

RBC Capital Upgrades Regeneron (REGN) to Outperform, Raises Price Target

In a recent development, RBC Capital upgraded the stock of biotechnology company Regeneron (NASDAQ: REGN) from “Sector Perform” to “Outperform.” Along with the upgrade, the analysts also raised the price target for the stock to $1,076 from $884 per share. This news has generated excitement among market participants as they anticipate potential growth opportunities for Regeneron.